Study identifies possible COVID-19 drugs -- including several that are FDA-approved
(University of Pennsylvania School of Medicine) Of the nine drugs found to reduce SARS-CoV-2 replication in respiratory cells, three already have FDA approval: the transplant-rejection drug cyclosporine, the cancer drug dacomitinib, and the antibiotic salinomycin.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news
More News: Cancer | Cancer & Oncology | COVID-19 | Infectious Diseases | Respiratory Medicine | Restasis | SARS | Study | Transplants | University of Pennsylvania